Innotox represents a genuine innovation in botulinum toxin formulation. Manufactured by Medytox Inc. — the pioneer of Korean botulinum toxin — Innotox is the world's first pre-diluted liquid botulinum toxin type A, eliminating the reconstitution step that has been standard practice since the first commercially available toxins were introduced.
What Makes Innotox Different
Traditional botulinum toxin products are supplied as vacuum-dried or lyophilised powders that must be reconstituted with sterile saline immediately before use. Innotox changes this entirely. The product is provided as a ready-to-use liquid solution at a concentration of 5 units per 0.1ml, meaning practitioners simply draw the required volume directly from o frasco.
This eliminates several sources of variability associated with powder reconstitution: the volume of diluent added, mixing technique, and the risk of dilution errors. In high-volume clinical settings, Innotox can meaningfully reduce preparation time and increase workflow efficiency.
Formaaulation Differences
Innotox uses polysorbate 80 as a stabiliser rather than the human serum albumin (HSA) found in most lyophilised toxins. This makes Innotox suitable for practitioners who require an albumin-free formulation. The liquid formulation also lacks the sodium chloride carrier associated with some other products.
The 50-unit presentation provides sufficient volume for multiple areas in a single session for most standard facial aesthetic protocols. At 5 units per 0.1ml, dosing mathematics are straightforward.
Storage Requirements
Unlike lyophilised toxins that can be stored at -20°C, Innotox must be stored refrigerated at 2–8°C and must not be frozen. This is an important consideration for practices managing multiple products with different storage requirements.
Clinical Considerations
Clinical outcomes with Innotox are comparable to lyophilised type A toxins for standard aesthetic indications. The onset and duration profile is consistent with other Korean botulinum toxin products. The liquid formulation does not affect the biological activity of the toxin complex.